Therapy of urticaria: German language version of the international S3-guideline;Teil 2: Therapie der Urtikaria - Deutschsprachige version der internationalen S3-leitlinie

Allergo Journal

Volumn 20, Issue 5, 2011, Pages 259-276

  Zuberbier, Torsten ^a   Aberer, Werner ^b   Brockow, Knut ^c   Grabbe, Jürgen ^d   Hamelmann, Eckard ^e   Hartmann, Karin ^f   Jakob, Thilo ^g   Maurer, Marcus ^a   Merk, Hans F ^h   Ollert, Markus ^c   Ruëff, Franziska ⁱ   Schmid Grendelmeier, Peter ^j   Staubach, Petra ^k   Voigtmann, Ingrid ^l   Wedi, Bettina ^m  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h RWTH AACHEN UNIVERSITY   (Germany)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^j UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^k UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^l Deutscher Allergie und Asthmabund eV (DAAB)   (Germany)

^m HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

Angioedema; Consensus; Therapy; Urticaria; Wheal

Indexed keywords

HISTAMINE H1 RECEPTOR ANTAGONIST;

CAUSAL ATTRIBUTION; COST BENEFIT ANALYSIS; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; DRUG EFFICACY; GERMANY; HUMAN; LANGUAGE; MEDICAL SOCIETY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT RESPONSE; URTICARIA;

EID: 79960500947     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (187)

1. Alomar A, Cuadra J de la, Fernandez J. Cetirizine vs astemizole in the treatment of chronic idiopathic urticaria. J Int Med Res 1990; 18: 358-65 (Pubitemid 20361362)
2. Andri L, Senna GE, Betteli C, Givanni S, Andri G, Lombardi C, Mezzelani P. A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria. Allergy 1993; 48: 358-65
3. Arck P, Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation 2006; 13: 347-56 (Pubitemid 47289518)
4. Asero R. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol 2007; 32: 34-8 (Pubitemid 46006362)
5. Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004; 113: 134-40 (Pubitemid 38096173)
6. Baiardini I, Giardini A, Pasquali M, Dignetti P, Guerra L, Specchia C, Braido F, Majani G, Walter Canonica G. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003; 58: 621-3 (Pubitemid 36831317)
7. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, Braga M, Lombardi C, Fassio O, Walter Canonica G. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005; 60: 1073-8 (Pubitemid 40942764)
8. Bajaj AK, Saraswat A, Upadhyay A, Damisetty R, Dhar S. Autologous serum therapy in chronic urticaria: old wine in a new bottle. Indian J Dermatol Venereol Leprol 2008; 74: 109-13 (Pubitemid 351519578)
9. Barlow RJ, Black AK, Greaves M. Treatment of severe, chronic urticaria with cyclosporine A. Eur J Dermatol 1993; 3: 273-5 (Pubitemid 23219641)
10. Barlow RJ, Greaves MW. Warfarin in the treatment of chronic urticaria/angio-edema. Br J Dermatol 1992; 126: 415-6
11. Barlow RJ, MacDonald DM, Black AK, Greaves MW. The effects of topical corticosteroids on delayed pressure urticaria. Arch Dermatol Res 1995; 287: 285-8
12. Baumgart KW, Mullins R. Use of hydroxychloroquine in refractory urticaria. J Allergy Clin Immunol 2000; 105: 795-6
13. Beck HI, Cramers M, Herlin T, Sondergaard I, Zachariae H. Comparison of oxatomide and clemastine in the treatment of chronic urticaria. A double blind study. Dermatologica 1985; 171: 49-51 (Pubitemid 15069682)
14. Beissert S, Stander H, Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol 2000; 42: 1030-2 (Pubitemid 30368674)
15. Belaich S, Bruttmann G, DeGreef H, Lachapelle JM, Paul E, Pedrali P, Tennstedt D. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 1990; 64: 191-4 (Pubitemid 20067099)
16. Bilsland D, Ferguson J. A comparison of cetirizine and terfenadine in the management of solar urticaria. Photodermatol Photoimmunol Photomed 1991; 8: 62-4
17. Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy 2010; 65: 138-9
18. Bissonnette R, Buskard N, McLean DI, Lui H. Treatment of refractory solar urticaria with plasma exchange. J Cutan Med Surg 1999; 3: 236-8 (Pubitemid 29301555)
19. Bleehen SS, Thomas SE, Greaves MW, Newton J, Kennedy CT, Hindley F, Marks R, Hazell M, Rowell NR, Fairiss GM. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol 1987; 117: 81-8 (Pubitemid 17096140)
20. Bonadonna P, Lombardi C, Senna G, Walter Canonica G, Passalacqua G. Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol 2003; 49: 714-6 (Pubitemid 37210290)
21. Borzova E, Rutherford A, Konstantinou GN, Leslie KS, Grattan CE. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: A pilot study. J Am Acad Dermatol 2008; 59: 752-7
22. Boyce JA. Successful treatment of cold-induced urticaria/ anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006; 117: 1415-8 (Pubitemid 43795744)
23. Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother 1996; 30: 1075-9 (Pubitemid 26332861)
24. Bressler RB, Sowell K, Huston DP. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial. J Allergy Clin Immunol 1989; 83: 756-63 (Pubitemid 19127941)
25. Brostoff J, Fitzharris P, Dunmore C, Theron M, Blondin P. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Allergy 1996; 51: 320-5 (Pubitemid 26232824)
26. Brozek JL, Baena-Cagnani CE, Bonini S, Walter Canonica G, Rasi G, Wijk RG van, Zuberbier T, Guyatt G, Bousquet J, Schünemann HJ. Methodology for development of the allergic rhinitis and its impact on asthma guideline 2008 update. Allergy 2008; 63: 38-46
27. Brzoza Z, Kasperska-Zajac A, Badura-Brzoza K, Matysiakiewicz J, Hese RT, Rogala B. Decline in dehydroepiandrosterone sulfate observed in chronic urticaria is associated with psychological distress. Psychosom Med 2008; 70: 723-8
28. Bullerkotte U, Wieczorek D, Kapp A, Wedi B. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy 2010; 65: 931-2
29. Camarasa JM, Aliaga A, Fernandez-Vozmediano JM, Fonseca E, Iglesias L, Tagarro I. Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial. Skin Pharmacol Appl Skin Physiol 2001; 14: 77-86
30. Cap JP, Schwanitz HJ, Czarnetzki BM. Effect of ketotifen in urticaria factitia and urticaria cholinergica in a crossover double-blind trial. Hautarzt 1985; 36: 509-11 (Pubitemid 15018821)
31. Cassano N, D'Argento V, Filotico R, Vena GA. Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study. Acta Derm Venereol 2005; 85: 254-5 (Pubitemid 40695172)
32. Correia I, Silva J, Filipe P, Gomes M. Solar urticaria treated successfully with intravenous high-dose immunoglobulin: a case report. Photodermatol Photoimmunol Photomed 2008; 24: 330-1
33. Czarnetzki BM, Algermissen B, Jeep S, Haas N, Nürnberg W, Müller K, Kropp JD. Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol 1994; 30: 500-1 (Pubitemid 24129449)
34. Dawn G, Urcelay M, Ah-Weng A, O'Neill SM, Douglas WS. Effect of high-dose intravenous immunoglobulin in de layed pressure urticaria. Br J Dermatol 2003; 149: 836-40 (Pubitemid 37412006)
35. Degonda M, Pichler WJ, Bircher A, Helbling A. Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients. Schweiz Rundsch Med Prax 2002; 91: 637-43 (Pubitemid 34619222)
36. Demaubeuge J, Tennstedt D, Broux R. Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine. Dermatologica 1982; 164: 386-94 (Pubitemid 12079126)
37. Di Lorenzo G, Pacor ML, Mansueto P, Esposito Pellitteri M, Lo Bianco C, Ditta V, Martinelli N, Rini GB. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 2004; 114: 619-25 (Pubitemid 39194938)
38. Diller G, Orfanos CE. Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study. Z Hautkr 1983; 58: 785-93
39. Doutre MS. Chronic urticaria and thyroid auto-immunity. Clin Rev Allergy Immunol 2006; 30: 31-7
40. Dover JS, Black AK, Ward AM, Greaves MW. Delayed pressure urticaria. Clinical features, laboratory investigations, and response to therapy of 44 patients. J Am Acad Dermatol 1988; 18: 1289-98
41. Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol 2005; 5: 408-12 (Pubitemid 41345308)
42. Dreyfus DH. Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema. Ann Allergy Asthma Immunol 2008; 100: 624-5 (Pubitemid 351829870)
43. Dubertret L, Murrieta AM, Tonet J. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. J Eur Acad Dermatol Venereol 1999; 12: 16-24 (Pubitemid 29132981)
44. Dubertret L, Pecquet C, Murrieta-Aguttes M, Leynadier F. Mizolastine in primary acquired cold urticaria. J Am Acad Dermatol 2003; 48: 578-83 (Pubitemid 36397022)
45. Dubertret L, Zalupca L, Cristodoulo T, Benea V, Medina I, Fantin S, Lahfa M, Pérez I, Izquierdo I, Arnaiz E. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo- controlled study. Eur J Dermatol 2007; 17: 223-8 (Pubitemid 46847786)
46. Engin B, Ozdemir M. Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2008; 22: 481-6 (Pubitemid 351436921)
47. Engin B, Ozdemir M, Balevi A, Mevlitoglu I. Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial. Acta Derm Venereol 2008; 88: 247-51 (Pubitemid 351743867)
48. Engler RJ, Squire E, Benson P. Chronic sulfasalazine thera py in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol 1995; 74: 155-9
49. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002; 110: 484-8
50. Ergon MC, Ilknur T, Yucesoy M, Ozkan S. Candida spp. colonization and serum anticandidal antibody levels in patients with chronic urticaria. Clin Exp Dermatol 2007; 32: 740-3 (Pubitemid 47609754)
51. Fradin MS, Ellis CN, Goldfarb MT, Voorhees JJ. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991; 25: 1065-7
52. Gimenez-Arnau A, Pujol RM, Ianosi S, Kaszuba A, Malbran A, Poop G, Donado E, Perez I, Izquierdo I, Arnaiz E, Rupatadine Urticaria Study Group. Rupatadine in the treatment of chronic idiopathic urticaria: a doubleblind, randomized, placebo-controlled multicentre study. Allergy 2007; 62: 539-46
53. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009; 23: 1099-91
54. Godse KV. Omalizumab in severe chronic urticaria. Indian J Dermatol Venereol Leprol 2008; 74: 157-8
55. Goh CL, Wong WK, Lim J. Cetirizine vs placebo in chronic idiopathic urticaria - a double blind randomised crossover study. Ann Acad Med Singapore 1991; 20: 328-30
56. Goldsobel AB, Rohr AS, Siegel SC, Spector SL, Katz RM, Rachelefsky GS, Drayton G, Indianer L, Peter JB, Barr RJ. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1986; 78: 867-73 (Pubitemid 17194639)
57. Grattan CE. Histamine-releasing autoantibodies in chronic urticaria. Skin Pharmacol 1991; 4 (Suppl 1): 64-70
58. Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003; 28: 123-7 (Pubitemid 36459612)
59. Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992; 339: 1078-80
60. Grattan CE, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, Kobza Black A, Greaves MW. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000; 143: 365-72
61. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000; 105: 664-72 (Pubitemid 30226438)
62. Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 1985; 12: 669-75 (Pubitemid 15106044)
63. Guzelbey O, Ardelean E, Magerl M, Zuberbier T, Maurer M, Metz M. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy 2008; 63: 1563-5
64. Handa S, Dogra S, Kumar B. Comparative efficacy of cetiri zine and fexofenadine in the treatment of chronic idiopathic urticaria. J Dermatolog Treat 2004; 15: 55-7 (Pubitemid 38252098)
65. Hani N, Hartmann K, Casper C, Peters T, Schneider LA, Hunzelmann N, Scharffetter-Kochanek K. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast. Acta Derm Venereol 2000; 80: 229
66. Hannuksela M, Kokkonen EL. Ultraviolet light therapy in chronic urticaria. Acta Derm Venereol 1985; 65: 449-50 (Pubitemid 15248273)
67. Harto A, Sendagorta E, Ledo A. Doxepin in the treatment of chronic urticaria. Dermatologica 1985; 170: 90-3 (Pubitemid 15164832)
68. Harvey RP, Wegs J, Schocket AL. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 1981; 68: 262-6 (Pubitemid 11027680)
69. Henz BM, Metzenauer P, O'Keefe E, Zuberbier T. Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses. Allergy 1998 a; 53: 180-3
70. Henz BM, Zuberbier T, Grabbe J, Monroe E. Urticaria - Clinical, diagnostic and therapeutic aspects. Berlin: Springer, 1998
71. Hilbert J, Radwanski E, Affrime MB, Perentesis G, Symchowicz S, Zampaglione N. Excretion of loratadine in human breast milk. J Clin Pharmacol 1988; 28: 234-9 (Pubitemid 19014771)
72. Horio T. Indications and action mechanisms of phototherapy. J Dermatol Sci 2000; 23 (Suppl 1): 17-21
73. Hudson-Peacock MJ, Farr PM, Diffey BL, Goodship THJ. Combined treatment of solar urticaria with plasmapheresis and PUVA. Br J Dermatol 1993; 128: 440-2 (Pubitemid 23105901)
74. James J, Warin RP. An assessment of the role of Candida albicans and food yeasts in chronic urticaria. Br J Dermatol 1971; 84: 227-37
75. Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 1981; 104: 369-81 (Pubitemid 11053482)
76. Juhlin L. Cetirizine in the treatment of chronic urticaria. Clin Ther 1991; 13: 81-6
77. Juhlin L. Inhibition of cold urticaria by desloratadine. J Dermatolog Treat 2004; 15: 51-9
78. Juhlin L, Arendt C. Treatment of chronic urticaria with cetirizine dihydrochloride a non-sedating antihistamine. Br J Dermatol 1988; 119: 67-71
79. Kalis B. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. Drugs 1996; 52 (Suppl 1): 30-4 (Pubitemid 26290227)
80. Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 1990; 86: 1014-8
81. Kamide R, Niimura M, Ueda H, Imamura S, Yamamoto S, Yoshida H, Kukita A. Clinical evaluation of ketotifen for chronic urticaria: multicenter double-blind comparative study with clemastine. Ann Allergy 1989; 62: 322-5 (Pubitemid 19116405)
82. Kaplan AP. Chronic urticaria. Possible causes, suggested treatment alternatives. Postgrad Med 1983; 74: 209-22
83. Kaplan AP. Urticaria: the relationship of duration of lesion to pathogenesis. Allergy Proc 1990; 11: 15-8 (Pubitemid 20228740)
84. Kaplan AP, Gray L, Shaff RE, Horakova Z, Beaven MA. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol 1975; 55: 394-402
85. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008; 122: 569-73
86. Kapp A, Pichler WJ. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. Int J Dermatol 2006; 45: 469-74
87. Kapp A, Wedi B. Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine. J Drugs Dermatol 2004; 3: 632-9
88. Kapp A, Guinnepain MT, Lachapelle JM, Murrieta- Aguttes M. Mizolastine in the treatment of chronic urticaria: a european clinical experience with 2452 patients managed in daily practice (PANEOS CU Study). In: Marone G, ed. Clinical Immunology and Allergy in Medicine. Naples: JGC Editions, 2003; 657-65
89. Kawashima M, Harada S. Efficacy and safety of fexofenadine HCl in Japanese patients with chronic idiopathic urticaria. Int Arch Allergy Immunol 2001; 124: 343-5 (Pubitemid 32304845)
90. Kawashima M, Harada S, Tango T. Review of fexofenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol 2002; 41: 701-6 (Pubitemid 35252053)
91. Kontou-Fili K, Maniakatou G, Demaka P, Paleologos G. Therapeutic effect of cetirizine 2HCl in delayed pressure urticaria. Health Sci Rev 1989; 3: 23-5
92. Kontou-Fili K, Maniatakou G, Demaka P, Gonianakis M, Palaiologos G, Aroni K. Therapeutic effects of cetirizine in delayed pressure urticaria: clinicopathologic findings. J Am Acad Dermatol 1991; 24: 1090-3
93. Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 2004; 64: 2515-36 (Pubitemid 39587219)
94. La Rosa M, Leonardi S, Marchese G, Corrias A, Barberio G, Oggiano N, Grimaldi I. Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. Ann Allergy Asthma Immunol 2001; 87: 48-53 (Pubitemid 32678334)
95. Lachapelle JM, Tennstedt D, Murrieta M. Comparative efficacy and safety of mizolastine 10 mg o. d. and cetirizine 10 mg o. d. versus placebo in chronic idiopathic urticaria. Allergy 1998; 53: 57
96. Lambert D, Hantzperg M, Danglas P, Bloom M. Doubleblind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria. Allerg Immunol 1993; 25: 235-40
97. Laurberg G. Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study. Acta Derm Venereol 1977; 57: 369-70 (Pubitemid 8159058)
98. Lawlor F, Ormerod AD, Greaves MW. Calcium antagonist in the treatment of symptomatic dermographism. Lowdose and high-dose studies with nifedipine. Dermatologica 1988; 177: 287-91
99. Lawlor F, Black AK, Ward AM, Morris R, Greaves MW. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine. Br J Dermatol 1989; 120: 403-8 (Pubitemid 19086629)
100. Levi-Schaffer F, Eliashar R. Mast cell stabilizing properties of antihistamines. J Invest Dermatol 2009; 129: 2549-51
101. Leynadier F, Duarte-Risselin C, Murrieta M. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group. Eur J Dermatol 2000; 10: 205-11 (Pubitemid 30186559)
102. Lorette G, Giannetti A, Pereira RS, Leynadier F, Murrieta-Aguttes M. One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group. J Eur Acad Dermatol Venereol 2000; 14: 83-90 (Pubitemid 32898944)
103. Magerl M, Philipp S, Manasterski M, Friedrich M, Maurer M. Successful treatment of delayed pressure urticaria with anti-TNF-alpha. J Allergy Clin Immunol 2007 a; 119: 752-4
104. Magerl M, Schmolke J, Siebenhaar F, Zuberbier T, Metz M, Maurer M. Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy 2007 b; 62: 1465-8
105. Magerl M, Schmolke J, Metz M, Zuberbier T, Siebenhaar F, Maurer M. Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg. Clin Exp Dermatol 2009; 34: 137-40
106. Maksimovic L, Fremont G, Jeanmougin M, Dubertret L, Viguier M. Solar urticaria successfully treated with intravenous immunoglobulins. Dermatology 2009; 218: 252-4
107. Mang R, Stege H, Budde MA, Ruzicka T, Krutmann J. Successful treatment of solar urticaria by extracorporeal photo chemotherapy (photopheresis) - a case report. Photodermatol Photoimmunol Photomed 2002; 18: 196-8
108. Mathelier-Fusade P. Drug-induced urticarias. Clin Rev Allergy Immunol 2006; 30: 19-23 (Pubitemid 43199218)
109. Matthews CN, Boss JM, Warin RP, Storari F. The effect of H1 and H2 histamine antagonists on symptomatic dermographism. Br J Dermatol 1979; 101: 57-61 (Pubitemid 10134317)
110. Metz M, Bergmann P, Zuberbier T, Maurer M. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 2008; 63: 247-9
111. Mlynek A, Magerl M, Hanna M, Lhachimi S, Baiardini I, Walter Canonica G Brzoza Z, Kasperska-Zajac A, Rogala B, Zalewska-Janowska A, Zuberbier T, Maurer M. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009; 64: 927-36
112. Moller A, Henning M, Zuberbier T, Czarnetzki-Henz BM. Epidemiology and clinical aspects of cold urticaria. Haut arzt 1996; 47: 510-4 (Pubitemid 26244745)
113. Monroe EW. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clin Ther 1992; 14: 17-21
114. Monroe EW, Cohen SH, Kalbfleisch J, Schulz CI. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol 1981; 117: 404-7
115. Monroe EW, Fox RW, Green AW, Izuno GT, Bernstein DI, Pleskow WW, Willis I, Brigante JR. Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticaria. J Am Acad Dermatol 1988; 19: 138-9
116. Monroe EW. Desloratidine for the treatment of chronic urticaria. Skin Therapy Lett 2002; 7: 1-2
117. Moscati RM, Moore GP. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Ann Emerg Med 1990; 19: 12-5 (Pubitemid 20045178)
118. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000; 84: 517-22 (Pubitemid 30365414)
119. Nettis E, Pannofino A, Cavallo E, Ferrannini A, Tursi A. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria. J Allergy Clin Immunol 2003; 112: 212-3 (Pubitemid 36819832)
120. Nettis E, Colanardi MC, Ferrannini A, Tursi A. Sodium benzoate-induced repeated episodes of acute urticaria/ angio-oedema: randomized controlled trial. Br J Dermatol 2004 a;151: 898-902 (Pubitemid 39482128)
121. Nettis E, Colanardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, doubleblind, placebo-controlled study. Clin Exp Allergy 2004 b; 34: 1401-7
122. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201 (Pubitemid 27062719)
123. O'Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, Barlow RJ, Winkelmann RK, Greaves MW. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998; 138: 101-6 (Pubitemid 28077945)
124. O'Donnell BF, Francis DM, Swana GT, Seed PT, Kobza BA, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol 2005; 153: 331-5 (Pubitemid 41228430)
125. Owoeye OA, Aina OF, Omoluabi PF, Olumide YM. An assessment of emotional pain among subjects with chronic dermatological problems in Lagos, Nigeria. Int J Psychiatry Med 2007; 37: 129-38 (Pubitemid 47267385)
126. Parsad D, Pandhi R, Juneja A. Stanozolol in chronic urticaria: a double blind, placebo controlled trial. J Dermatol 2001; 28: 299-302 (Pubitemid 32681357)
127. Parslew R, Pryce D, Ashworth J, Friedmann PS. Warfarin treatment of chronic idiopathic urticaria and angiooedema. Clin Exp Allergy 2000; 30: 1161-5 (Pubitemid 30619770)
128. Pereira C, Tavares B, Carrapatoso I, Loureiro G, Faria E, Machado D, Chieira C. Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria. Eur Ann Allergy Clin Immunol 2007; 39: 237-42
129. Peremans W, Mertens RL, Morias J, Campaert H. Oxa tomide in the treatment of chronic urticaria. A double-blind placebo-controlled trial. Dermatologica 1981; 162: 42-50
130. Peyri J, Vidal J, Marrón J, Fonseca E, Suárez E, Ledo A, Zayas JM, Luria X. Ebastine in chronic urticaria: a doubleblind placebo-controlled study. J Dermatolog Treat 1991; 2: 51-3
131. Pigatto PD, Valsecchi RH. Chronic urticaria: a mystery. Allergy 2000; 55: 306-8 (Pubitemid 30146137)
132. Pollack CV, Jr., Romano TJ. Outpatient management of acute urticaria: the role of prednisone. Ann Emerg Med 1995; 26: 547-51
133. Pontasch MJ, White LJ, Bradford JC. Oral agents in the management of urticaria: patient perception of effectiveness and level of satisfaction with treatment. Ann Pharmacother 1993; 27: 730-1 (Pubitemid 23184908)
134. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999; 140: 667-71 (Pubitemid 29191386)
135. Potter PC, Kapp A, Maurer M, Guillet G, Jian AM, Hauptmann P, Finlay AY. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Allergy 2009; 64: 596-604
136. Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, Mirakian R, Walker SM, Huber PA, Nasser SM; British Society for Allergy and Clinical Immunology (BSACI). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007; 37: 631-50
137. Reese I, Zuberbier T, Bunselmeyer B, Erdmann S, Henzgen M, Fuchs T, Jäger L, Kleine-Tebbe J, Lepp U, Niggemann B, Raithel M, Saloga J, Vieths S, Werfel T. Diagnostic approach for suspected pseudoallergic reaction to food ingredients. J Dtsch Dermatol Ges 2009; 7: 70-7
138. Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004; 34: 182-6 (Pubitemid 38651038)
139. Reimers A, Pichler C, Helbling A, Pichler WJ, Yawalkar N. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 2002; 32: 1763-8 (Pubitemid 35463863)
140. Riccioni G, Di Ilio C, Conti P, Theoharides TC, D'Orazio N. Advances in therapy with antileukotriene drugs. Ann Clin Lab Sci 2004; 34: 379-87
141. Ring J, Hein R, Gauger A, Bronsky E, Miller B. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol 2001; 40: 72-6 (Pubitemid 32201239)
142. Ring J, Brockow K, Ollert M, Engst R. Antihistamines in urticaria. Clin Exp Allergy 1999; 29 (Suppl 1):31-7 (Pubitemid 29145152)
143. Roelandts R. Diagnosis and treatment of solar urticaria. Dermatol Ther 2003; 16: 52-6 (Pubitemid 36665996)
144. Sands MF, Blume JW, Schwartz SA. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol 2007; 120: 979-81 (Pubitemid 47534214)
145. Serhat IH, Ozturk S, Akcali C, Kirtak N, Tarakcioglu M. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. J Dermatol 2008; 35: 276-82 (Pubitemid 351678094)
146. Shahar E, Bergman R, Guttman-Yassky E, Pollack S. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Int J Dermatol 2006; 45: 1224-7 (Pubitemid 44560379)
147. Sharpe GR, Shuster S. In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone. Br J Dermatol 1993 a; 129: 575-9
148. Sharpe GR, Shuster S. The effect of cetirizine on symptoms and wealing in dermographic urticaria. Br J Dermatol 1993 b; 129: 580-3 (Pubitemid 23336456)
149. Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 2009; 123: 672-9
150. Simons FE. Prevention of acute urticaria in young children with atopic dermatitis. J Allergy Clin Immunol 2001; 107: 703-6 (Pubitemid 32397760)
151. Spangler DL, Vanderpool GE, Carroll MS, Tinkelman DG. Terbutaline in the treatment of chronic urticaria. Ann Allergy 1980; 45: 246-7 (Pubitemid 10021675)
152. Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 2007; 99: 190-3 (Pubitemid 47264781)
153. Spector SL, Tan RA. Advances in allergic skin disease: Omalizumab is a promising therapy for urticaria and angioedema. J Allergy Clin Immunol 2008; 121: 1351-8
154. Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, Church DS, Dimitrov V, Church MK. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-totreat urticaria. J Allergy Clin Immunol 2010; 125: 676-82
155. Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I, Opper B, Magerl M, Lüdtke R, Kromminga A, Maurer M. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006; 212: 150-9 (Pubitemid 43260731)
156. Staubach P, Vonend A, Burow G, Metz M, Magerl M, Maurer M. Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds. Mycoses 2008; 52: 334-8
157. Stellato C, Paulis A de, Ciccarelli A, Cirillo R, Patella V, Casolaro V, Marone G. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol 1992; 98: 800-4
158. St-Pierre JP, Kobric M, Rackham A. Effect of ketotifen treatment on cold-induced urticaria. Ann Allergy 1985; 55: 840-3 (Pubitemid 16228128)
159. Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000; 43: 24-30 (Pubitemid 30439708)
160. Thormann J, Laurberg G, Zachariae H. Oral sodium cromoglycate in chronic urticaria. Allergy 1980; 35: 139-41 (Pubitemid 10130409)
161. Torrelo A, Harto A, Ledo A. Interferon therapy for chronic urticaria. J Am Acad Dermatol 1995; 32: 684-5
162. Toubi E, Blant A, Kessel A, Golan TD. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997; 52: 312-6 (Pubitemid 27166233)
163. Valero A, Herdman M, Bartra J, Ferrer M, Jáuregui I, Dávila I, Cuvillo A del, Montoro J, Mullol J, Sastre J, Walter Canonica G, Baiardini I. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). J Investig Allergol Clin Immunol 2008; 18: 426-32
164. Vena GA, D'Argento V, Cassano N, Mastrolonardo M. Sequential therapy with nimesulide and ketotifen in delayed pressure urticaria. Acta Derm Venereol 1998 a; 78: 304-5
165. Vena GA, Puddu P, eds. Proceedings of the international symposium on urticaria. Bari: Publ Scientif, 1998 b: 85-9
166. Vena GA, Cassano N, Colombo D, Peruzzi E, Pigatto P. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2006 a; 55: 705-9 (Pubitemid 44444850)
167. Vena GA, Cassano N, D'Argento V, Milani M. Clobetasol propionate 0.05 % in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, doubleblind, placebo-controlled trial. Br J Dermatol 2006 b; 154: 353-6 (Pubitemid 43382710)
168. Villas MF, Contreras FJ, Lopez Cazana JM, Lopez Serrano MC, Martinez AF. A comparison of new non-sedating and classical antihistamines in the treatment of primary acquired cold urticaria (ACU). J Investig Allergol Clin Immunol 1992; 2: 258-62
169. Wanderer AA, Ellis EF. Treatment of cold urticaria with cyproheptadine. J Allergy Clin Immunol 1971; 48: 366-71
170. Wanderer AA, St Pierre JP, Ellis EF. Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. Arch Dermatol 1977; 113: 1375-7 (Pubitemid 8198678)
171. Watson NT, Weiss EL, Harter PM. Famotidine in the treatment of acute urticaria. Clin Exp Dermatol 2000; 25: 186-9 (Pubitemid 30340542)
172. Wedi B. Urtikaria. J Deutsch Dermatol Ges 2008; 6: 306-17
173. Wedi B, Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol 2002; 3: 273-82 (Pubitemid 34615390)
174. Wedi B, Kapp A. Chronic urticaria: assessment of current treatment. Exp Rev Clin Immunol 2005; 1: 459-73
175. Wedi B, Kapp A. Urticaria and angioedema. In: Mahmoudi M, ed. Allergy: practical diagnosis and management. New York: Mc Graw Hill, 2008: 84-94
176. Wedi B, Raap U, Kapp A. Chronic urticaria and infections. Curr Opin Allergy Clin Immunol 2004; 4: 387-96 (Pubitemid 39274080)
177. Weller K, Maurer M. Desloratadine inhibits human skin mast cell activation and histamine release. J Invest Dermatol 2009; 129: 2723-6
178. Wong E, Eftekhari N, Greaves MW, Ward AM. Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol 1987; 116: 553-6 (Pubitemid 17036883)
179. Zuberbier T, Althaus C, Chantraine-Hess S, Czarnetzki BM. Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol 1994; 31: 978-81 (Pubitemid 24365037)
180. Zuberbier T, Aberer W, Burtin B, Rihoux JP, Czarnetzki BM. Efficacy of cetirizine in cholinergic urticaria. Acta Derm Venereol 1995 a; 75: 147-9
181. Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki BM. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol 1995 b; 75: 484-7
182. Zuberbier T, Ifflander J, Semmler C, Henz BM. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol 1996 a; 76: 295-7
183. Zuberbier T, Münzberger C, Haustein U, Trippas E, Burtin B, Mariz SD, Henz BM. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology 1996 b; 193: 324-7
184. Zuberbier T, Greaves MW, Juhlin L, Kobza-Black A, Maurer D, Stingl G, Henz BM. Definition, classification, and routine diagnosis of urticaria: a consensus report. J Investig Dermatol Symp Proc 2001; 6: 123-7 (Pubitemid 33758584)
185. Zuberbier T, Pfrommer C, Specht K, Vieths S, Bastl-Borrmann R, Worm M, Henz BM. Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol 2002; 109: 343-8 (Pubitemid 34158304)
186. Zuberbier T, Bindslev-Jensen C, Walter Canonica G, Grattan CE, Greaves MW, Henz BM, Kapp A, Kozel MM, Maurer M, Merk HF, Schäfer T, Simon D, Vena GA, Wedi B; EAACI/GA2LEN/EDF. EAACI/GALEN/EDF guideline: management of urticaria. Allergy 2006; 61: 321-31
187. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM, Grattan CEH, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-43